Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.
Trommer M, Yeo SY, Persigehl T, Bunck A, Grüll H, Schlaak M, Theurich S, von Bergwelt-Baildon M, Morgenthaler J, Herter JM, Celik E, Marnitz S, Baues C. Trommer M, et al. Among authors: celik e. Front Pharmacol. 2019 May 14;10:511. doi: 10.3389/fphar.2019.00511. eCollection 2019. Front Pharmacol. 2019. PMID: 31156434 Free PMC article.
Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma.
Baues C, Görgen H, Semrau R, Nast-Kolb B, Assenmacher K, Celik E, Morgenthaler J, Rosenbrock J, Trommer M, Houbois C, Kobe C, Kriz J, Engert A, Marnitz S. Baues C, et al. Among authors: celik e. Leuk Lymphoma. 2019 Dec;60(13):3244-3250. doi: 10.1080/10428194.2019.1623888. Epub 2019 Jun 22. Leuk Lymphoma. 2019. PMID: 31232136
Corrigendum: Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.
Trommer M, Yeo SY, Persigehl T, Bunck A, Grüll H, Schlaak M, Theurich S, von Bergwelt-Baildon M, Morgenthaler J, Herter JM, Celik E, Marnitz S, Baues C. Trommer M, et al. Among authors: celik e. Front Pharmacol. 2020 Jan 31;10:1615. doi: 10.3389/fphar.2019.01615. eCollection 2019. Front Pharmacol. 2020. PMID: 32082149 Free PMC article.
Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching.
Trommer M, Kinsky J, Adams A, Hellmich M, Schlaak M, von Bergwelt-Baildon M, Celik E, Rosenbrock J, Morgenthaler J, Herter JM, Linde P, Mauch C, Theurich S, Marnitz S, Baues C. Trommer M, et al. Among authors: celik e. Cancers (Basel). 2020 Aug 27;12(9):2429. doi: 10.3390/cancers12092429. Cancers (Basel). 2020. PMID: 32867046 Free PMC article.
Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences.
Galldiks N, Abdulla DSY, Scheffler M, Wolpert F, Werner JM, Hüllner M, Stoffels G, Schweinsberg V, Schlaak M, Kreuzberg N, Landsberg J, Lohmann P, Ceccon G, Baues C, Trommer M, Celik E, Ruge MI, Kocher M, Marnitz S, Fink GR, Tonn JC, Weller M, Langen KJ, Wolf J, Mauch C. Galldiks N, et al. Among authors: celik e. J Nucl Med. 2021 Apr;62(4):464-470. doi: 10.2967/jnumed.120.248278. Epub 2020 Sep 4. J Nucl Med. 2021. PMID: 32887757 Free PMC article.
679 results